Import, Customs Classification and VAT for Medical Devices in Belarus

1. Key takeaways

Importing medical devices into Belarus requires, beyond registration status, a preliminary question of commodity attribute confirmation — a question that simultaneously determines the customs duty rate and the VAT treatment. The expert institution provides an official service that issues precisely this conclusion: a finding that the goods intended for import are medical devices, medical equipment, or raw materials and components for their production. The service exists because border classification and regulatory classification do not automatically agree: a customs code describes a physical article, while the registration regime describes a regulated product category, and borderline items sit uncomfortably between the two vocabularies. An official conclusion bridges them, and because the same document feeds three downstream decisions — whether the product counts as a device, whether the import enjoys a VAT exemption, and which duty rate applies — obtaining it early is the cheapest way to prevent rework in three separate processes at once. Planning imports without it means committing to a duty rate and a tax treatment before the product’s regulatory nature has been authoritatively settled.

2. Legal basis

The rows in the table describe two layers of the import problem. The first row is the operational instrument: the institution’s service list, which names the official conclusion on commodity attributes and states in its own terms that the conclusion serves VAT exemption and duty rate determination. The remaining rows describe the regulatory layer within which the goods must sit: registration as the prerequisite for lawful circulation under No. 211, the statutory anchor in Article 39-1 of the Healthcare Law, and the circulation stage obligations imposed by No. 177 once the product is on the market. Both layers must be satisfied before commercial import proceeds.

3. Expert insights

Insight one: attribute confirmation is a service that solves three problems at once. A single official conclusion simultaneously serves registration (defining whether the article falls within the device category), VAT (whether the import is exempt) and customs duty (which rate applies). For borderline products, obtaining this conclusion before planning customs clearance prevents rework at three separate points later. The alternative — clearing first and arguing classification afterwards — exposes the importer to duty reassessment, loss of the VAT exemption and, in the worst case, a finding that the goods were circulated without the required regulatory status. One document obtained early is cheaper than three disputes defended late.

Insight two: registration status and customs clearance are in series, not in parallel. A product that has not completed registration, or does not fall within an exemption from registration, cannot be lawfully sold and circulated even if it clears customs successfully. Logistics should therefore be scheduled against registration progress, not against production completion. Companies that ship against finished-goods readiness create inventory that is legally inert at the border: physically in the country, commercially unusable, and accruing storage cost while the registration file is still under review.

Insight three: sample imports and commercial imports are handled differently. The import of samples used for registration testing and the commercial batch import that follows completed registration differ in document requirements and in the statements of use they require. Sample imports should expressly state their purpose, so that the goods are not treated as commercial circulation. A sample shipment that is documented like a commercial one invites duty and tax treatment appropriate to commerce, and blurs the record that the regulatory authority later expects to see about how test articles reached the laboratory.

Insight four: the clearance logic differs under the Union route. Where the Union-wide registration is used and recognised in Belarus, the documentary basis for import is the Union registration certificate, which is not identical to the national certificate. Dual-track projects should therefore prepare two clearance document templates, one per certificate type. Assuming a single template serves both routes produces files that fail at the border for lack of the correct certificate reference, at precisely the moment when shipment schedules are least able to absorb a delay.

4. Practical recommendations

The recommendations below sequence the import work so that the official conclusion does its three jobs in time.

1. Obtain attribute confirmation first for borderline products. Apply for the expert institution’s conclusion on use and attributes before planning clearance and tax treatment, so that duty rate and VAT questions are answered on the basis of an official document.
2. Schedule logistics against registration progress. Make goods dispatch depend on reaching a saleable regulatory status, not on production completion, so that no inventory accumulates at the border awaiting a certificate.
3. Mark sample imports with their purpose. State expressly on the documents that the goods are for registration testing only, keeping them distinct from commercial circulation in the customs record.
4. Prepare two clearance document templates for dual-track projects. Match each template to its certificate type — national or Union — so that clearance files always carry the correct certificate reference.

5. Verification checklist

• □ An official attribute confirmation conclusion has been obtained for borderline products
• □ Logistics scheduling has been based on registration progress
• □ Sample import documents state that the goods are for registration testing only
• □ Two sets of clearance document templates have been prepared for dual-track projects
• □ Customs duty rates and VAT treatment have been aligned with the customs broker

Regulatory information verified as of 30 October 2026.

In the Eurasian Economic Union market, GRZAN concentrates its core capabilities on three areas. First, distinguishing between the applicability conditions and the remaining time windows of the two channels, the Union-wide registration and the national registration of each member state — the national registration procedure of Belarus has been fully re-routed by the Council of Ministers Resolution No. 211 of 28 April 2026 (state register number 6-1/55925, effective 2026-05-01), which compresses the total timeframe for preliminary technical work to 90 calendar days, keeps the list of such work closed, and prohibits the implementing organisation from expanding it, while the window for submitting applications under the national procedure takes 2027-12-31 as its key milestone, so route selection must be decided in step with the time window. Second, local authorised representative services: GRZAN can act as the statutory representative of a manufacturer in Belarus, undertaking registration submission, responses to technical queries, changes to the registration dossier and post-market reporting obligations, and it has updated its liaison mechanisms after the Council of Ministers Resolution No. 378 of 27 July 2026 (effective 2026-07-30) transferred adverse event functions to the state agency State Pharmaceutical Supervision (Gosfarmnadzor). Third, quality system and testing support: GRZAN assists in establishing a quality management system that meets ISO 13485 requirements and organises technical documentation according to the target route — for the national route, per the annexes to Ministry of Health Resolution No. 55; for the Union route, per EEC Council Decision No. 46.

For business enquiries: info@grzanglobal.com